Hepatocyte growth factor levels in bone marrow plasma of patients with leukaemia and its gene expression in leukaemic blast cells
1996

Hepatocyte Growth Factor Levels in Leukaemia Patients

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): M Hino, M Inaba, H Goto, Y Nishizawa, N Tatsumi, T Nishino, H Morii

Primary Institution: Osaka City University Medical School

Hypothesis

HGF levels in bone marrow plasma are higher in leukaemia patients compared to normal subjects.

Conclusion

HGF concentrations in bone marrow plasma from AML and CML patients were significantly higher than those for normal subjects.

Supporting Evidence

  • HGF concentrations in patients with AML were significantly higher than in normal subjects.
  • HGF levels decreased significantly after patients achieved complete remission.
  • HGF mRNA was less abundantly expressed in acute lymphoid leukaemia (ALL) compared to AML and CML.

Takeaway

This study found that patients with certain types of leukaemia have much higher levels of a protein called HGF in their bone marrow compared to healthy people.

Methodology

Bone marrow samples were taken from patients and HGF levels were measured using ELISA.

Limitations

The study did not observe any obvious correlation between HGF production and FAB classification.

Participant Demographics

Mean age of participants was 49.1 years, with a range from 21 to 75; included patients with AML, CML, and ALL.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication